HOME >> MEDICINE >> NEWS
Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial

New Orleans, LA (March 27, 2007) -- Heart attacks are caused by a build-up and instability of plaque in the coronary arteries, which is often a result of chronic inflammation of the blood vessel walls. A study presented today at the American College of Cardiologys 56th Annual Scientific Session assessed whether adding a novel agent with antioxidant and anti-inflammatory properties to optimal medical therapy would reduce coronary events and death among patients with heart disease. ACC.07 is the premier cardiovascular medical meeting, bringing together more than 30,000 cardiologists to further breakthroughs in cardiovascular medicine.

While the trial results did not demonstrate a difference with the use of succinobucol (AGI-1067) versus placebo on the primary endpoint of a composite of major adverse cardiovascular events, the study did achieve a number of other important predefined endpoints, including a reduction in the composite of hard atherosclerotic clinical endpoints, composed of cardiovascular death, myocardial infarction (heart attack) and stroke with a relative risk reduction of 19 % (p=0.028); as well as an improvement in several key diabetes parameters, including fewer patients developing diabetes with a relative risk reduction of 64 % (p<0.0001), and better glycemic control (reduction of HbA1c of 0.5% at twelve months, p<0.0001) in patients randomized to succinobucol.

2 2 2 ALPHA Trial

The trial was entitled Effects of the Novel Anti-Oxidant and Anti-Inflammatory Agent Succinobucol (AGI-1067) on Clinical Events in Patients With a Recent Acute Coronary Syndrome: The Aggressive Reduction of Inflammation Stops Events (ARISE) Study. We are pleased with the meaningful improvement of patient outcomes observed with AGI-1067 (succinobucol) in the ARISE trial, which should help to address the burden of cardiovascular risk that exists despite our effective contemporary treatments. said JeanClaude Tardif, M.D., Director of Resea
'"/>

Contact: Leslie Humbel
lhumbel@spectrumscience.com
504-613-2418
American College of Cardiology
27-Mar-2007


Page: 1 2

Related medicine news :

1. Novel candidate biomarker for heart failure also strongly predicts risk of death
2. Novel treatments may help alleviate constipation, IBS in women
3. Novel catheter technique successfully patches holes in the heart
4. Novel Ames Lab composite may replace depleted uranium
5. Novel computed imaging technique uses blurry images to enhance view
6. Novel brain areas associated with the recognition of gender, ethnicity and the identity of faces
7. Novel program enhances dementia caregivers quality of life
8. Novel gene therapy may lead to cure in hemophilia A patients
9. Novel therapy combinations gain ground in treating hepatitis
10. Novel stem cell technology leads to better spinal cord repair
11. Novel virus entry mechanism could lead to new drugs against poxviruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 28, 2020 , ... Officials with ... clinically integrated network (CIN) and the group purchasing organization run by Allegheny Health ... establish a heart failure program at Mon Health Medical Center. ...
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot doctors ... Michigan, Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki ... within the clinic and at the hospital. We have been seeing patients in the ...
(Date:5/26/2020)... ... May 26, 2020 , ... Loyale ... patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service messaging solutions complement ... texts, IVR reminders and email messages tailored to each stage of their ...
(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. is introducing three Toilet ... whimsical and delicious in these complicated times,” he said, in announcing the new wines. ... ($24.99). The Chardonnay and Red Wine Blend are sourced in the Napa Valley; the ...
(Date:5/21/2020)... Pa. (PRWEB) , ... May 21, 2020 , ... ... Inc. and an industry leader in cancer biomarker assays, announced today that Cigna ... list. Cigna Corporation is a global health service company dedicated to improving the ...
Breaking Medicine News(10 mins):
(Date:6/2/2020)... ... June 02, 2020 , ... As the leading human capital ... COVID-19 it is working with its corporate team, its consultants, and its healthcare ... host of digital resources. Harmony’s leadership team recognized the extraordinary efforts of the ...
(Date:6/2/2020)... ... June 02, 2020 , ... SCFHP members who call SCFHP’s 24/7 ... and, depending on the inquiry, can now virtually consult with an available physician. Once ... their primary care doctor to ensure seamless care. The nurse advice line with the ...
(Date:5/30/2020)... DALLAS (PRWEB) , ... May 29, 2020 , ... ... launched a unique return-to-work mobile and web based solution People1 Care ... People1 Care helps companies transition into the 'new normal’ through daily wellness screenings, ...
Breaking Medicine Technology:
Cached News: